በአዮዋ ለሉፑስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሉፑስ የሚደረጉ 6 ጥናቶች በአዮዋ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በአዮዋ ውስጥ ያሉ ከተሞች
Official study text (English)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50319, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 16 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06617325A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Iowa, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07085104A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of Iowa, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT06925542Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Univeristy of Iowa, Iowa City
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT07180537A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- University of Iowa, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ5 ጁን 2026 · NCT06613360ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።